Worldwide Growth Seen in Respiratory Device Market
By HospiMedica International staff writers Posted on 07 Apr 2014 |
The global respiratory device market continues to grow, mainly due to the aging of the world population and increasing incidence of respiratory diseases. These are the latest findings of Kalorama Information (New York, NY, USA), an independent medical market research firm.
The bulk of revenue of the USD 47 billion-dollar market, which includes inhalers, oxygen systems, oximeters, and other equipment, is derived from the 36 billion inhaler segment. The segment comprises metered dose inhalers or dry powder versions, which are commonly used for the treatment of asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), or any lung disease characterized by chronic or acute inflammation. They consist of a micronized form of drug in a propellant under pressure with surfactants to prevent clumping of drug crystals.
Other products such as endotracheal tubes, tracheostomy tubes, nasopharyngeal catheters, and oxygen mask devices, which comprise a smaller portion of the market, will see faster growth, since many are disposable and used in hospital or homecare settings. Material innovations are also driving a rising demand in products focusing on comfort and wearability, such as the Devilbiss (Somerset, PA, USA) EasyFit SilkGel Nasal and Full Face Mask, and the Teleflex Softech Plus nasal cannula. The market encompasses many different products to help treat and monitor respiratory conditions, as well as many large and small manufacturers.
“The market for inhalers continues to grow based on the aging of the world population, an increase in respiratory diseases and a general increase in conditions,” said report author Kalorama analyst Mary Anne Crandall. “Because of the ease of use and advancements in inhaler delivery, drug companies and drug delivery manufacturers are increasing interest in this technology.”
According to the report, the device market will grow at a 4.6% compound annual growth rate (CAGR), reaching 59 billion in 2018; revenue growth in the high-demand comfort and wearability products is predicted to be 50% faster than the overall market.
Related Links:
Kalorama Information
Devilbiss
The bulk of revenue of the USD 47 billion-dollar market, which includes inhalers, oxygen systems, oximeters, and other equipment, is derived from the 36 billion inhaler segment. The segment comprises metered dose inhalers or dry powder versions, which are commonly used for the treatment of asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), or any lung disease characterized by chronic or acute inflammation. They consist of a micronized form of drug in a propellant under pressure with surfactants to prevent clumping of drug crystals.
Other products such as endotracheal tubes, tracheostomy tubes, nasopharyngeal catheters, and oxygen mask devices, which comprise a smaller portion of the market, will see faster growth, since many are disposable and used in hospital or homecare settings. Material innovations are also driving a rising demand in products focusing on comfort and wearability, such as the Devilbiss (Somerset, PA, USA) EasyFit SilkGel Nasal and Full Face Mask, and the Teleflex Softech Plus nasal cannula. The market encompasses many different products to help treat and monitor respiratory conditions, as well as many large and small manufacturers.
“The market for inhalers continues to grow based on the aging of the world population, an increase in respiratory diseases and a general increase in conditions,” said report author Kalorama analyst Mary Anne Crandall. “Because of the ease of use and advancements in inhaler delivery, drug companies and drug delivery manufacturers are increasing interest in this technology.”
According to the report, the device market will grow at a 4.6% compound annual growth rate (CAGR), reaching 59 billion in 2018; revenue growth in the high-demand comfort and wearability products is predicted to be 50% faster than the overall market.
Related Links:
Kalorama Information
Devilbiss
Latest Business News
- Johnson & Johnson Acquires Cardiovascular Medical Device Company Shockwave Medical
- Mindray to Acquire Chinese Medical Device Company APT Medical
- Olympus Acquires Korean GI Stent Maker Taewoong Medical
- Karl Storz Acquires British AI Specialist Innersight Labs
- Stryker to Acquire French Joint Replacement Company SERF SAS
- Medical Illumination Acquires Surgical Lighting Specialist Isolux
- 5G Remote-Controlled Robots to Enable Even Cross-Border Surgeries
- International Hospital Federation Announces 2023 IHF Award Winners
- Unprecedented AI Integration Transforming Surgery Landscape, Say Experts
- New WHO Guidelines to Revolutionize AI in Healthcare
- Getinge Acquires US-Based Medical Equipment Provider Healthmark Industries
- Global Surgical Lights Market Driven by Increasing Number of Procedures
- Global Capsule Endoscopy Market Driven by Demand for Accurate Diagnosis of Gastrointestinal Conditions
- Global OR Integration Market Driven by Need for Improved Workflow Efficiency and Productivity
- Global Endoscopy Devices Market Driven by Increasing Adoption of Endoscopes in Surgical Procedures
- Global Minimally Invasive Medical Devices Market Driven by Benefits of MIS Procedures